127 related articles for article (PubMed ID: 74972)
1. Casein and other tumor markers in relation to cancer of the breast.
Zangerle PF; Thirion A; Hendrick JC; Franchimont P
Antibiot Chemother (1971); 1978; 22():141-8. PubMed ID: 74972
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous assays of cancer-associated antigens in various neoplastic disorders.
Franchimont P; Zangerle PF; Nogarede J; Bury J; Molter F; Reuter A; Hendrick JC; Collette J
Cancer; 1976 Dec; 38(6):2287-95. PubMed ID: 63315
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous assays of cancer associated antigens in benign and malignant breast diseases.
Franchimont P; Zangerle PF; Hendrick JC; Reuter A; Colin C
Cancer; 1977 Jun; 39(6 Suppl):2806-12. PubMed ID: 68808
[No Abstract] [Full Text] [Related]
4. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen levels (carcinoembryonic antigen, human chorionic gonadotropin, and alpha-fetoprotein) antedating the diagnosis of cancer in the Framingham study.
Williams RR; McIntire KR; Waldmann TA; Feinleib M; Go VL; Kannel WB; Dawber TR; Castelli WP; McNamara PM
J Natl Cancer Inst; 1977 Jun; 58(6):1547-51. PubMed ID: 68118
[TBL] [Abstract][Full Text] [Related]
7. alpha-Fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin and its beta subunit in metastatic choriocarcinoma: short-term follow-up and determinations of resistance during chemotherapy.
Gips H; Vahrson H; Bailer P; Korte K
Oncology; 1980; 37(3):157-62. PubMed ID: 6153786
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical demonstration of several tumour markers in neoplastic and preneoplastic states of the uterine mucosa.
Hustin J
Gynecol Obstet Invest; 1978; 9(1):3-15. PubMed ID: 81793
[TBL] [Abstract][Full Text] [Related]
9. Tumour antigens associated with primary mediastinal choriocarcinoma.
Forest JC; Talbot J; Pagé M; Loiselle JM
Can Med Assoc J; 1977 Dec; 117(12):1386-8. PubMed ID: 73406
[TBL] [Abstract][Full Text] [Related]
10. alpha-Fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) demonstrated in the immature glands of mediastinal teratocarcinoma: a case report.
Irie T; Watanabe H; Kawaoi A; Takeuchi J
Cancer; 1982 Sep; 50(6):1160-5. PubMed ID: 6179592
[TBL] [Abstract][Full Text] [Related]
11. Human chorionic gonadotropin in gastric carcinoma. A useful marker for bone metastasis.
Yonemura Y; Oyama S; Sugiyama K; Sawa T; Shima Y; Kamata T; Hashimoto T; Miwa K; Miyazaki I
Int Surg; 1989; 74(2):84-7. PubMed ID: 2473961
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
13. Choriocarcinoma: expression of tumor- and trophoblast-associated antigens in patients with low chorionic gonadotropin excretion.
Seppälä M; Rutanen EM; Ranta T; Aho I; Nieminen U; Unnérus HA; Saksela E
Cancer; 1976 Nov; 38(5):2065-70. PubMed ID: 62610
[TBL] [Abstract][Full Text] [Related]
14. Significance of CEA, AFP, SP1 and HCG as tumor markers in ovarian carcinoma.
Pulay T; Csömör S; Mészáros K; Szarka G; Csabay L; Szinnyai A
Neoplasma; 1987; 34(5):595-600. PubMed ID: 2447510
[TBL] [Abstract][Full Text] [Related]
15. Serum biochemical markers in lung cancer.
Burt RW; Ratcliffe JG; Stack BH; Cuthbert J; Kennedy RS; Corker CS; Franchimont P; Spilg WG; Stimson WH
Br J Cancer; 1978 May; 37(5):714-7. PubMed ID: 77672
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal antigens in ovarian cyst fluids.
Kraly DH; Koh SH; Hay DL; Cauchi MN
Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
[TBL] [Abstract][Full Text] [Related]
19. Markers and characteristics of human SCLC cell lines. Neuroendocrine markers, classical tumor markers, and chromosomal characteristics of permanent human small cell lung cancer cell lines.
Bepler G; Jaques G; Koehler A; Gropp C; Havemann K
J Cancer Res Clin Oncol; 1987; 113(3):253-9. PubMed ID: 2438285
[TBL] [Abstract][Full Text] [Related]
20. The clinical significances of carcinoembryonic proteins in patients with ovarian carcinoma.
Tottori K; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):142-50. PubMed ID: 6164739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
